Characterization of the small molecule kinase inhibitor SU11248 
(Sunitinib/SUTENT) in vitro and in vivo – Towards response prediction in cancer 
therapy with kinase inhibitors

Bairlein, Michaela

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Thesis

Characterization of the small molecule kinase inhibitor SU11248 (Sunitinib/SUTENT) in vitro and in vivo – Towards response prediction in cancer therapy with kinase inhibitors

MPS-Authors

/persons/resource/persons77700

Bairlein, Michaela
Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Bairlein, M. (2010). Characterization of the small molecule kinase inhibitor SU11248 (Sunitinib/SUTENT) in vitro and in vivo – Towards response prediction in cancer therapy with kinase inhibitors. PhD Thesis, Technische Universität, München.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-57FC-7

Abstract

There is no abstract available